An Update on PEPFAR Reauthorization
This Policy Watch provides an update on the status of PEPFAR reauthorization, which expired on March 25, 2025, allowing certain provisions to lapse.
View the Latest: Abortion
Filter
-
-
Voters Chose Republicans This Year in Spite of Differences on Health Care
Quick TakeDespite [Republicans’] victories, there are signs in the polling that voters are not necessarily aligned with some of the policies Republicans may pursue when it comes to health care.
-
The Mexico City Policy: An Explainer
Issue BriefExplore an overview of the Mexico City Policy, which, when in effect, requires foreign NGOs to certify that they will not “perform or actively promote abortion as a method of family planning” using funds from any source (including non-U.S. funds) as a condition for receiving U.S. government global health assistance.
-
The Hyde Amendment and Coverage for Abortion Services Under Medicaid in the Post-Roe Era
Issue BriefThis brief details the federal programs that are affected by the Hyde Amendment and laws and regulations that have a similar goal, provides estimates on the share of women insured by Medicaid affected by the law, reviews the impact of the law on their access to abortion services, and discusses the potential effect if the law were to be repealed.
-
A New Reproductive Health Landscape? Possible Actions that Could be Undertaken During the Second Trump Administration
Issue BriefThis brief reviews some of the possible actions of the incoming Trump administration and new Congress based on campaign statements, policies implemented by the first Trump administration, and proposals forwarded by allied conservative think tanks and antiabortion advocacy groups.
-
Classifying Misoprostol and Mifepristone as Controlled Substances: Implications for the Management of Non-Abortion Related Conditions
Issue BriefThis data note analyzes employer-sponsored insurance and Medicaid claims data to see how mifepristone and misoprostol—two drugs used in the medication abortion regimen—are prescribed for reasons other than abortion including management of miscarriages, abnormal bleeding or hemorrhage, as well as IUD insertions and other conditions.
-
Out-of-Pocket Costs for Abortion Care Among Individuals Enrolled in Employer Sponsored Insurance Plans
Issue BriefTo improve the affordability of abortion services, many states have passed laws that require state-regulated plans to cover the full cost of abortion services for their enrollees. This data note documents the costs associated with abortion care in private plans. Also, KFF analyzes how out of pocket spending has been affected by state laws that require full coverage of abortion services.
-
Women and Abortion in Florida: Findings from the 2024 KFF Women’s Health Survey
Issue BriefThis brief provides information about abortion experiences, awareness, and attitudes of Florida women ages 18 to 49, based on findings from the 2024 KFF Women’s Health Survey, a nationally representative survey on health care issues.
-
Women and Abortion in Arizona: Findings from the 2024 KFF Women’s Health Survey
Issue BriefThis brief provides information about abortion experiences, awareness, and attitudes of Arizona women ages 18 to 49, based on findings from the 2024 KFF Women’s Health Survey, a nationally representative survey on health care issues.
-
Abortion Experiences, Knowledge, and Attitudes Among Women in the U.S.: Findings from the 2024 KFF Women’s Health Survey
Issue BriefThis brief provides new information from the 2024 KFF Women's Health Survey about women’s experiences with abortion, the fallout of overturning Roe v. Wade, women’s knowledge about abortion laws in their states including medication abortion, as well as their opinions on the legality of abortion.